Quick Answer
Arcus Biosciences, Inc. reported Common Stock Shares Outstanding of 125.30 million shares for the year ending 2025.
- Arcus Biosciences, Inc. showed an increase of +35.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Arcus Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Arcus Biosciences, Inc.'s Common Stock Shares Outstanding has grown by 2,962.9%.
- Historical annual values: Fiscal year 2025: 125.30 million shares | Fiscal year 2024: 92.20 million shares | Fiscal year 2023: 75.50 million shares | Fiscal year 2022: 72.90 million shares | Fiscal year 2021: 70.80 million shares | Fiscal year 2020: 65.11 million shares | Fiscal year 2019: 45.93 million shares | Fiscal year 2018: 44.54 million shares | Fiscal year 2017: 4.09 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: